Clevidipine
![](/Images/godic/202501/05/Clevidipine_structure.svg1216.png")
![](/Images/godic/202501/05/Clevidipine_3D1216.png")
![Cleviprex is supplied in sterile, pre-mixed, ready-to-use 50 mL or 100 mL vials](/Images/godic/202501/05/Cleviprex_50ml_100ml_vial1216.jpg")
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.
It was approved by the United States Food and Drug Administration on August 1, 2008.